These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8536781

  • 1. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
    Zorzos J, Zizi A, Bakiras A, Pectasidis D, Skarlos DV, Zorzos H, Elemenoglou J, Likourinas M.
    Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E, Skarlos D, Tamvakis N, Psaropoulou P, Blana E, Bamias A, Legaki S, Aravantinos G, Deliveliotis C, Dimopoulos K.
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
    Summerhayes IC, McIlhinney RA, Ponder BA, Shearer RJ, Pocock RD.
    J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
    [Abstract] [Full Text] [Related]

  • 4. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N, Rubenstone A, Mlsna J, Davidsohn I.
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [Abstract] [Full Text] [Related]

  • 5. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
    Pocock RD, Ibrahim SK, Sloane JP, Ponder BA, Shearer RJ.
    Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
    [Abstract] [Full Text] [Related]

  • 6. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
    Loy TS, Alexander CJ, Calaluce RD.
    Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688
    [Abstract] [Full Text] [Related]

  • 7. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
    Hoshi S, Orikasa S, Numata I, Nose M.
    J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Draeger BJ.
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [Abstract] [Full Text] [Related]

  • 9. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P.
    Anticancer Res; 1988 Dec; 8(3):443-9. PubMed ID: 3389746
    [Abstract] [Full Text] [Related]

  • 10. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
    Fradet Y, Cordon-Cardo C, Whitmore WF, Melamed MR, Old LJ.
    Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
    Hellström I, Hellström KE, Rollins N, Lee VK, Hudkins KL, Nepom GT.
    Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
    [Abstract] [Full Text] [Related]

  • 12. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL, Delahunt B, Bethwaite PB, Thornton A.
    Anticancer Res; 1997 May; 17(1B):685-7. PubMed ID: 9066602
    [Abstract] [Full Text] [Related]

  • 13. Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies.
    Dotsikas G, Konowalchuk T, Major PP, Kovac PE, Ward GK, Stewart SS, Price GB, Elhilali MM, Mackillop WJ.
    Br J Cancer; 1987 Oct; 56(4):439-44. PubMed ID: 3689660
    [Abstract] [Full Text] [Related]

  • 14. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
    Clemo FA, DeNicola DB, Carlton WW, Walker E, Morrison WB.
    Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
    [Abstract] [Full Text] [Related]

  • 15. A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization.
    Takahashi N, Takahashi S, Takahashi K, Suzuki T, Funyu T.
    J Urol; 1987 Jul; 138(1):207-11. PubMed ID: 2439711
    [Abstract] [Full Text] [Related]

  • 16. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system.
    Knuechel R, Burgau M, Rueschoff J, Hofstaedter F.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993 Jul; 64(3):137-44. PubMed ID: 7902171
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T, Yagita H, Hashimoto Y.
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [Abstract] [Full Text] [Related]

  • 18. T-antigen in normal and neoplastic urothelium.
    Limas C, Lange P.
    Cancer; 1986 Sep 15; 58(6):1236-45. PubMed ID: 3742450
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of human carcinoma-associated antigen in urothelial carcinoma of the bladder.
    Yao JL, Bourne PA, Yang Q, Lei J, di Sant'Agnese PA, Huang J.
    Arch Pathol Lab Med; 2004 Jul 15; 128(7):785-7. PubMed ID: 15214822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.